Functional neuroimaging of cognition impaired by a classical antihistamine, d-chlorpheniramine

British Journal of Pharmacology

Volumn 129, Issue 1, 2000, Pages 115-123

  Okamura, Nobuyuki ^a,b   Yanai, Kazuhiko ^b   Higuchi, Makoto ^a,b   Sakai, Jun ^b   Iwata, Ren ^a   Ido, Tatsuo ^a   Sasaki, Hidetada ^b   Watanabe, Takehiko ^b   Itoh, Masatoshi ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Antihistamines; Brain; Cerebral blood flow; Chlorpheniramine; Cognition; H1 receptor antagonists; Positron emission tomography; Receptor occupancy; Sedation in man

Indexed keywords

ANTIHISTAMINIC AGENT; CHLORPHENIRAMINE; HISTAMINE H1 RECEPTOR;

ADULT; ARTICLE; BRAIN BLOOD FLOW; BRAIN FUNCTION; CINGULATE GYRUS; CLINICAL ARTICLE; COGNITION; COGNITIVE DEFECT; DOSE RESPONSE; FRONTAL LOBE; HUMAN; HUMAN EXPERIMENT; MALE; MESENCEPHALON; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEPTOR OCCUPANCY; SOMNOLENCE; TEMPORAL LOBE; VISUAL DISCRIMINATION;

EID: 0033964014     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702994     Document Type: Article

References (49)

1. Adelsberg, B.R. (1997). Sedation and performance issues in the treatment of allergic conditions. Arch. Int. Med., 157, 494-500.
2. Aso, T. & Sakai, Y. (1988). Effects of terfenadine on actual driving performance. Jpn. J. Pharmacol. Ther., 19, 681-688.
3. Coull, J.T., Frith, C.D., Dolan, R.J., Frackowiak, R.S.J. & Grasby, P.M. (1997). The neural correlates of the noradrenergic modulation of human attention, arousal, and learning. Eur. J. Neurosci., 9, 589-598.
4. Fleckenstein, A.E., Lookingland, K.J. & Moore, K.E. (1994). Activation of noradrenergic neurons projecting to the dience-phalon following central administration of histamine is mediated by H1 receptors. Brain Res., 638, 243-247.
5. Friston, K.J., Ashburner, J., Frith, C.D., Poline, J.P., Heather, J.D. & Frackowiak, R.S.J. (1995a). Spatial registration and normalization of images. Hum. Brain Mapp., 2, 165-189.
6. Friston, K.J., Holmes, A.P., Worsley, K.J., Poline, J.P, Frith, C.D. & Frackowiak, R.S.J. (1995b). Statistical maps in functional imaging: a general linear approach. Hum. Brain Mapp., 2, 189-210.
7. Fujiwara, T., Watanuki, S., Yamamoto, S., Miyake, M., Seo, S., Itoh, M., Ishii, K., Orihara, H., Fukuda, H., Satoh, T., Kitamura, K., Tanaka, K., Takahashi, S. (1997). Performance evaluation of a large axial field-of-view PET scanner: SET-2400W. Ann. Nucl. Med., 11, 307-313.
8. Furey, M.L., Pietrini, P., Haxby, J.V., Alexander, G.E., Lee, H.C., Vanmeter, J., Grady, C.L., Shetty, U., Rapoport, S.I., Shapiro, M.B. & Freo, U. (1997). Cholinergic stimulation alters performance and task-specific regional cerebral blood flow during working memory. Proc. Natl. Acad. Sci. U.S.A., 94, 6512-6516.
9. Ghatan, P.H., Ingvar, M., Eriksson, L., Stone-Elander, S., Serrander, M., Ekberg, K. & Wahren, J. (1998). Cerebral effects of nicotine during cognition in smokers and non-smokers. Psychopharmacology, 136, 179-189.
10. Goetz, D.W., Jacobson, J.M., Murnane, J.E., Reid, M.J., Repperger, D.W., Goodyear, C. & Martin, M.E. (1989). Prolongation of simple and choice reaction times in a double-blind comparison of twice-daily hydroxyzine versus terfenadine. J. Allergy Clin. Immunol., 84, 316-322.
11. Goldman-Rakic, P.S. (1988). Topography of cognition: Parallel distributed networks in primate association cortex. Annu. Rev. Neurosci., 11, 137-156.
12. Hendeles, L. (1993). Efficacy and safety of antihistamines and expectorants in nonprescription cough and cold preparations. Pharmacotherapy, 13, 154-158.
13. 15O. I. Theory and error analysis. J. Nucl. Med., 24, 782-789.
14. Hoddes, E., Zarcone, V.P., Smythe, H., Phillips, R. & Dement, W.C. (1973). Quantification of sleepiness: a new approach. Psychophysiology, 10, 431-436.
15. Johannsen, P., Jakobsen, J., Bruhn, P., Hansen, S.B., Gee, A., Stodkilde-Jorgensen, H. & Gjedde, A. (1997). Cortical sites of sustained and devided attention in normal elderly humans. Neuroimage, 6, 145-155.
16. Jouvet, M. (1996). Waking mechanisms: multiple networks in the mesencephalic reticular formation. Arch. Physiol. Biochem., 104, 762-769.
17. Kemp, J.P., Buckley, C.E. & Gershwin, M.E. (1985). Multicenter, double-blind, placebo-controlled trial of terfenadine in seasonal allergic rhinitis and conjunctivitis. Ann. Allergy, 54, 502-509.
18. Khateb, A., Fort, P., Pegna, A., Jones, B.E. & Muhlethaler, M. (1995). Cholinergic nucleus basalis neurons are excited by histamine in vitro. Neuroscience, 69, 495-506.
19. Kimford, J., Meador, M.D., Loring, D.W., Thompson, E.E. & Thompson, W.O. (1989). Differential cognitive effects of terfenadine and chlorpheniramine. J. Allergy Clin. Immunol., 84, 322-325.
20. Kinomura, S., Larson, J., Gulyas, B. & Roland, P.E. (1996). Activation by attention of the human reticular formation and thalamic intralaminar nuclei. Science, 271, 512-515.
21. Lewin, J.S., Friedman, L., Wu, D., Miller, D.A., Thompson, L.A., Klein, S.K., Wise, A.L., Hedera, P., Buckley, P., Meltzer, H., Friedland, R.P. & Duerk, J.L. (1996). Cortical localization of human sustained attention: detection with functional MR using a visual vigilance paradigm. J. Comput. Assist. Tomogr., 20, 695-701.
22. Lin, J.S., Hou, Y., Sakai, K. & Jouvet, M. (1996). Histaminergic descending inputs to the mesopontine tegmentum and their role in the control of cortical activation and wakefulness in the cat. J. Neurosci., 16, 1523-1537.
23. Lin, J.S., Sakai, K. & Jouvet, M. (1988). Evidence for histaminergic arousal mechanisms in the hypothalamus of cat. Neuropharmacology, 27, 1523-1537.
24. 11C-methyl]-(-)-cocaine PET studies in human subjects. J. Cereb. Blood Flow Metab., 10, 740-747.
25. Meador, K.J., Loring, D.W., Thompson, E.E. & Thompson, W.O. (1989). Differential cognitive effects of terfenadine and chlorpheniramine. J. Allergy Clin. Immunol., 84, 322-325.
26. Mejia, M.A., Itoh, M., Watabe, H., Fujiwara, T. & Nakamura, T. (1994). Specified nonlinearity correction of oxygen-15-water regional cerebral blood flow Images without blood sampling. J. Nucl. Med., 35, 1870-1877.
27. Meltzer, E.O. (1990). Performance effects of antihistamines. J. Allergy Clin. Immunol., 86, 613-619.
28. Nicholson, A.N. (1983). Antihistamines and sedation. Lancet, 2, 211-212.
29. Nicholson, A.N. (1985). Central effects of H1 and H2 antihistamines. Aviat. Space Environ. Med., 56, 293-298.
30. Nolen, T.M. (1997). Sedative effects of antihistamines: safety, performance, learning, and quality of life. Clin. Ther., 19, 39-55.
31. Nyberg, S., Farde, L., Bartfai, A. & Halldin, C. (1995). Central D2 receptor occupancy and effects of zuclopenthixol acetate in humans. Int. Clin. Psychopharmacol., 10, 221-227.
32. Pardo, J.V., Fox, P.T. & Raichle, M.E. (1991). Localization of a human system for sustained attention by positron emission tomography. Nature, 349, 61-64.
33. Peets, E.A., Jackson, M. & Symchowicz, S. (1972). Metabolism of chlorpheniramine maleate in man. J. Pharmacol. Exp. Ther., 180, 464-474.
34. Posner, M.I. & Petersen, S.E. (1990). The attention system of the human brain. Annu. Rev. Neurosci., 13, 25-42.
35. 15O. II. Implementation and validation. J. Nucl. Med., 24, 790-798.
36. Reiner, P.B. & Kamondi, A. (1994). A. Mechanism of antihistamine-induced sedation in the human brain: H1 receptor activation reduces a background leakage potassium current. Neuroscience, 59, 579-588.
37. Rice, V.J. & Snyder, H.L. (1993). The effects of Benadryl and Hismanal on psychomotor performance and perceived performance. Aviat. Space Environ. Med., 64, 726-734.
38. Schwartz, J.C., Arrang, J.M., Garbarg, M., Pollard, H. & Ruat, M. (1991). Histaminergic transmission in the mammalian brain. Physiol. Rev., 71, 1-51.
39. Seidel, W.F., Cohen, S., Bliwise, N.G. & Dement, W.C. (1987). Cetirizine effects on objective measures of daytime sleepiness and performance. Ann. Allergy, 59, 58-62.
40. Simons, F.E.R. & Simons, K.J. (1994). The pharmacology and use of H1-receptor-antagonist drugs. N. Engl. J. Pharmacol., 330, 1663-1670.
41. Smith, M.B.H. & Feldman, W. (1993). Over-the-counter cold medications. JAMA, 269, 2258-2263.
42. Talairach, J. & Tourneaux, P. (1988). A Co-planar Stereotaxic Atlas of a Human Brain. Thieme, Stuttgart.
43. Tasaka, K., Chung, Y.H., Mio, M., & Kamei, C. (1993). The pathway responsible for EEG synchronization and effect of histamine on this system. Brain Res. Bull., 32, 365-371.
44. Valjakka, A., Vartiainen, J., Kosunen, H., Hippelainen, M., Pesola, P., Olkkonen, H., Airaksinen, M.M. & Tuomisto, L. (1996). Histaminergic modulation of neocortical spindling and slow-wave activity in freely behaving rats. J. Neural Transm., 103, 1265-1280.
45. Wada, H., Inagaki, N., Yamatodani, A. & Watanabe, T. (1991). Is the histaminergic neuron system a regulatory center for whole-brain activity?. Trends Neurosci., 14, 415-418.
46. Watanabe, T., Taguchi, Y., Shiosaka, S., Tanaka, J., Kubota, H., Terano, Y., Tohyama, M. & Wada, H. (1984). Distribution of the histaminergic neuron system in the central nervous system of rats; a fluorescent immunohistochemical analysis with histidine decarboxylase as a marker. Brain Res., 295, 13-25
47. Witek, Jr, T.J., Canestrari, D.A., Miller, R.D., Yang, J.Y. & Riker, D.K. (1995). Characterization of daytime sleepiness and psychomotor performance following H1 receptor antagonists. Ann. Allergy, Asthma, Immunol., 74, 419-426.
48. Yanai, K., Ryu, J.H., Watanabe, T., Iwata, R., Ido, T., Sawai, Y., Ito, T. & Itoh, M. (1995). Histamine H1 receptor occupancy in human brains after single oral doses of histamine H1 antagonists measured by positron emission tomography. Br. J. Pharmacol., 116, 1649-1655.
49. 11C]doxepin and positron emission tomography. Neurosci. Lett., 137, 145-148.